JP2005154283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005154283A5 JP2005154283A5 JP2003390695A JP2003390695A JP2005154283A5 JP 2005154283 A5 JP2005154283 A5 JP 2005154283A5 JP 2003390695 A JP2003390695 A JP 2003390695A JP 2003390695 A JP2003390695 A JP 2003390695A JP 2005154283 A5 JP2005154283 A5 JP 2005154283A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- vitamin
- arginine
- formulation
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 6
- 239000004475 Arginine Substances 0.000 claims 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 3
- 229930003268 Vitamin C Natural products 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 235000019154 vitamin C Nutrition 0.000 claims 3
- 239000011718 vitamin C Substances 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 241000711573 Coronaviridae Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003390695A JP4671092B2 (ja) | 2003-11-20 | 2003-11-20 | ウイルス感染予防および対策 |
| EP04719654A EP1693058A4 (en) | 2003-11-20 | 2004-03-11 | PREVENTION OF AND MEASURES FOR VIRUS INFECTIONS |
| CA002547881A CA2547881A1 (en) | 2003-11-20 | 2004-03-11 | Prevention of and countermeasures against viral infection |
| PCT/JP2004/003215 WO2005049007A1 (ja) | 2003-11-20 | 2004-03-11 | ウイルス感染予防および対策 |
| US12/385,667 US20090209640A1 (en) | 2003-11-20 | 2009-04-15 | Prevention of and countermeasures against viral infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003390695A JP4671092B2 (ja) | 2003-11-20 | 2003-11-20 | ウイルス感染予防および対策 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005154283A JP2005154283A (ja) | 2005-06-16 |
| JP2005154283A5 true JP2005154283A5 (https=) | 2005-12-02 |
| JP4671092B2 JP4671092B2 (ja) | 2011-04-13 |
Family
ID=34616351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003390695A Expired - Fee Related JP4671092B2 (ja) | 2003-11-20 | 2003-11-20 | ウイルス感染予防および対策 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1693058A4 (https=) |
| JP (1) | JP4671092B2 (https=) |
| CA (1) | CA2547881A1 (https=) |
| WO (1) | WO2005049007A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5656350B2 (ja) * | 2008-10-08 | 2015-01-21 | ポッカサッポロフード＆ビバレッジ株式会社 | 抗ｓａｒｓコロナウイルス剤及び抗ｓａｒｓコロナウイルス作用促進方法 |
| WO2022089677A1 (de) * | 2020-10-27 | 2022-05-05 | Gosbert Weth | Antivirale thrombosehemmende und tumorschädigende zusammensetzung mit arginin und thiocyanat |
| EP4313020A4 (en) * | 2021-03-26 | 2025-01-29 | Emory University | MANAGING THE ACUTE AND LONG-TERM EFFECTS OF CORONAVIRUS INFECTIONS AND RELATED COMPOUNDS |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA939265A (en) * | 1967-11-18 | 1974-01-01 | Yoshitaka Ikezuki | Injectable compositions for alleviating the pain incurred from administrations of injections |
| JPS57100179A (en) * | 1980-12-16 | 1982-06-22 | Nissan Gosei Kogyo Kk | Mixing method of particulate or granular saccharide with amino acid |
| JPS62221624A (ja) * | 1986-03-24 | 1987-09-29 | Shizuoka Pref Gov | 魚類のウイルス病予防．治療方法 |
| DE3728367C1 (de) * | 1987-08-25 | 1988-09-01 | Burkhard Steglich | Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen |
| US6608109B2 (en) * | 1991-11-20 | 2003-08-19 | Allen Ann De Wees | Composition comprising L-arginine as a muscle growth stimulant and use thereof |
| GB9318611D0 (en) * | 1993-09-08 | 1993-10-27 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| JPH10139683A (ja) * | 1996-11-14 | 1998-05-26 | Otsuka Pharmaceut Co Ltd | 免疫賦活栄養補給組成物 |
| JP2000281575A (ja) * | 1999-03-25 | 2000-10-10 | Kyokuto Internatl Corp | 油脂被覆ビタミンｃ経口給与による、家畜の免疫力増強、並びにストレスの防除及び損耗を防止する方法 |
| JP4601745B2 (ja) * | 1999-08-23 | 2010-12-22 | ハウスウェルネスフーズ株式会社 | 免疫賦活効果を相乗的に増強した製剤 |
| WO2001015777A1 (en) * | 1999-08-31 | 2001-03-08 | Oxycal Laboratories, Inc. | Pulmonary-administration of mineral ascorbates |
| US20020197352A1 (en) * | 2001-04-02 | 2002-12-26 | Pacifichealth Laboratories, Inc. | Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise |
| DE10128910A1 (de) * | 2001-06-15 | 2002-12-19 | Beiersdorf Ag | Verwendung von Wirkstoffkombinationen aus Arginin und Ascorbinsäure zur Hautstraffung |
| CN1164267C (zh) * | 2003-06-02 | 2004-09-01 | 中国科学院上海药物研究所 | 绿原酸的医学用途及它的制剂 |
| CN1476836A (zh) * | 2003-06-10 | 2004-02-25 | 中国科学院上海药物研究所 | 紫锥松果菊提取物的抗sars作用及其药物组合物 |
-
2003
- 2003-11-20 JP JP2003390695A patent/JP4671092B2/ja not_active Expired - Fee Related
-
2004
- 2004-03-11 EP EP04719654A patent/EP1693058A4/en not_active Withdrawn
- 2004-03-11 WO PCT/JP2004/003215 patent/WO2005049007A1/ja not_active Ceased
- 2004-03-11 CA CA002547881A patent/CA2547881A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
| BR0009437A (pt) | Amido pré-gelatinizado em uma formulação de liberação controlada | |
| WO2006056711A3 (fr) | Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire | |
| AR067184A1 (es) | Uso de 6-(3-cloro-2-fluorbencil)-1-[(2s)-1-hidroxi-3-metilbutan-2-il]-7-metoxi-4-oxo-1,4-dihidroquinolina-3-carboxilico. composicion farmaceutica | |
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| JP2010503695A5 (https=) | ||
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| WO2009026473A3 (en) | Stabilized therapeutic compositions and formulations | |
| MY142403A (en) | Oral dosage forms for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient | |
| CA2401569A1 (en) | Low dose entecavir formulation and use | |
| JP2007508326A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| PT1425005E (pt) | Composicao farmaceutica que compreende lumiracoxib | |
| CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
| JP2005511619A5 (https=) | ||
| JP2006507295A5 (https=) | ||
| ITMI20011338A0 (it) | Composizioni farmaceutiche orali a rilascio immediato del principio attivo | |
| JP2011516544A5 (https=) | ||
| JP2008515980A5 (https=) | ||
| JP2020536098A5 (https=) | ||
| JP2008088189A5 (https=) | ||
| JP2005154283A5 (https=) |